v3.22.4
Fourth Quarter Financial Results (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Oct. 28, 2022
Sep. 09, 2022
Jun. 23, 2022
Feb. 17, 2022
Oct. 29, 2021
Sep. 10, 2021
Jun. 17, 2021
Feb. 18, 2021
Oct. 30, 2020
Sep. 11, 2020
Jun. 17, 2020
Feb. 20, 2020
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]                                
Net revenues                         $ 15,121 $ 58,054 $ 56,197 $ 45,804
Gross margin                         10,951      
Net earnings attributable to AbbVie Inc.                         $ 2,473 $ 11,836 $ 11,542 $ 4,616
Basic earnings per share (in dollars per share)                         $ 1.39 $ 6.65 $ 6.48 $ 2.73
Diluted earnings per share (in dollars per share)                         1.38 6.63 6.45 2.72
Cash dividends declared per common share (in dollars per share) $ 1.48 $ 1.41 $ 1.41 $ 1.41 $ 1.41 $ 1.30 $ 1.30 $ 1.30 $ 1.30 $ 1.18 $ 1.18 $ 1.18 $ 1.48 $ 5.71 $ 5.31 $ 4.84